If disclosed publicly, this period is decreased. Commensurate with report of any initial patent filing, unless the invention is being licensed as an unpatented biological material or research tool. At this time, NIH must be the primary agency for the particular invention in order to exercise this licensing option. In this situation, as there will be no initial patent filing, the confirmatory license is due to NIH at the time the licensed but not patented status is elected in Edison. Paper form generated electronically and faxed, or via paper documentation.
Title then vests with the government.
If disclosed publicly, this period is decreased. Effectively a waiver to the government. Cognizant NIH ICD Techology Development Coordinator may elect title on behalf of the government. The government must waive its rights before any other party can elect title. Second, the inventor must agree to all terms associated with invention reporting as detailed in 37 CFR 401 and must pursue patent prosecution and commercialization.